"Both the UK and China are a great match in their shared focus on science and innovation," said Pascal Soriot, CEO of AstraZeneca, on Friday during the UK-China Business Forum in Beijing. He highlighted China's growing role as a key contributor to biopharmaceutical innovation and noted that UK Prime Minister Keir Starmer's visit to China is a strong signal of global collaboration. Just a day earlier, AstraZeneca announced a 100-billion-yuan ($15 billion) investment in China by 2030 to expand research and development and pharmaceutical manufacturing.